Our new paper on marketing of unproven stem cell interventions and the role of medical societies in patient advocacy and education is published in Cytotherapy.
This work was in collaboration with Daniel J. Weiss, Professor of Medicine, University of Vermont College of Medicine; Leigh Turner, Associate Professor, Center for Bioethics, University of Minnesota; and Aaron D. Levine, Associate Professor, School of Public Policy, Georgia Institute of Technology.
Congratulations to Keri Dame and Matt Lawton on their next career steps! Keri is now an ORISE Fellow in the Division of Applied Regulatory Science of the FDA and Matt is a graduate student at Boston University’s Program in Biomedical Sciences.
July 7th 2017
Congratulations to Keri Dame for the succesfull defense of her thesis, making her the first PhD graduate of the Ikonomou lab!
April 1st, 2017
Dr. Ikonomou and other members of the American Thoracic Society Stem Cell Working Group wrote an AJRCCM patient-centric Public Health information piece on unproven “stem cell” interventions for lung disease. Thanks to the ATS, the COPD Foundation, the Asian Pacific Society of Respirology, the Pulmonary Hypertension Association of Canada and the Malaysian Thoracic Society for featuring this piece on their websites.
March 31st, 2017
Check out the “Development and Bioengineering of Lung Regeneration” chapter written by KIWi group’s PIs Andrew Wilson and Laertis Ikonomou. It is part of the “Organ Regeneration Based on Developmental Biology” book (Springer Singapore).
February 11th, 2017
The National Herald, a Greek-American publication, features an interview with Dr. Ikonomou about the latest work published by our lab on efficient thyroid progenitor derivation from pluripotent stem cells.
